Amy Ponte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amy Ponte has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Karen Lynn Niemchick
School of Interdisciplinary Health, College of Health Professions, Grand Valley State University, 301 Michigan Street NE, Grand Rapids, MI 49503, USA
2 shared publications Ally Goerge
Master of Public Health Program, Grand Valley State University, Grand Rapids, MI, USA
1 shared publication- Anastasia M. Jacko
Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA
1 shared publication - Andrea L. Durst
Human Genetics Department, University of Pittsburgh School of Public Health, Pittsburgh, USA
1 shared publication Camille Level
Centre de Génétique, FHU TRANSLAD, CHU Dijon Bourgogne, Dijon, France
1 shared publication- Camille Schubert
Adelaide Health Technology Assessment (AHTA), School of Public Health, University of Adelaide, Adelaide, SA, Australia
1 shared publication
Latest Publications
- 4 June 2026
- Published by Springer Nature in European Journal of Human Genetics
Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing
Affordability and value-for-money are key factors that will inform decisions about implementation of genomic newborn screening (gNBS) as a population-based program. Given the methodological and data-related challenges to evaluating health and economic outcomes of gNBS, there is a need for discussion and knowledge sharing amongst investigators responsible for conducting such evaluations. The International Consortium on Newborn Sequencing (ICoNS) includes academic and commercial gNBS pilot and implementation programs, and the ICoNS Economics Subcommittee assembles health economists who are involved in the evaluation of these programs. This paper summarizes the reported approaches taken by gNBS researchers to assess the health, psychosocial, and economic outcomes of gNBS and provides recommendations for reporting of gNBS economic evaluations developed by an international working group of health economists. We surveyed 12 ICoNS-affiliated project investigators involved in the design of health economics and outcomes evaluation protocols, the results of which were supplemented through ICoNS Economics Subcommittee discussion. Investigators reported making economic evaluation methodological design choices that reflect both the gNBS study design and adaptation to local policy questions and stakeholder input. Investigators reported plans to conduct cost-effectiveness analyses (n = 7, 58%) and/or cost-utility analyses (n = 5, 42%). Recommendations for reporting gNBS economic evaluations include aspects of genetic condition identification, screening and follow-up care pathways, and health and cost outcomes. Going forward, making transparent study design choices and sharing lessons learned could advance understanding of outcomes in a methodologically complex context and inform researchers planning to design similar studies in the future.
- 4 June 2026
- Published by Springer Nature in European Journal of Human Genetics
Health economic evaluations of genomic newborn screening: Approaches by studies within the international consortium on newborn sequencing
Affordability and value-for-money are key factors that will inform decisions about implementation of genomic newborn screening (gNBS) as a population-based program. Given the methodological and data-related challenges to evaluating health and economic outcomes of gNBS, there is a need for discussion and knowledge sharing amongst investigators responsible for conducting such evaluations. The International Consortium on Newborn Sequencing (ICoNS) includes academic and commercial gNBS pilot and implementation programs, and the ICoNS Economics Subcommittee assembles health economists who are involved in the evaluation of these programs. This paper summarizes the reported approaches taken by gNBS researchers to assess the health, psychosocial, and economic outcomes of gNBS and provides recommendations for reporting of gNBS economic evaluations developed by an international working group of health economists. We surveyed 12 ICoNS-affiliated project investigators involved in the design of health economics and outcomes evaluation protocols, the results of which were supplemented through ICoNS Economics Subcommittee discussion. Investigators reported making economic evaluation methodological design choices that reflect both the gNBS study design and adaptation to local policy questions and stakeholder input. Investigators reported plans to conduct cost-effectiveness analyses (n = 7, 58%) and/or cost-utility analyses (n = 5, 42%). Recommendations for reporting gNBS economic evaluations include aspects of genetic condition identification, screening and follow-up care pathways, and health and cost outcomes. Going forward, making transparent study design choices and sharing lessons learned could advance understanding of outcomes in a methodologically complex context and inform researchers planning to design similar studies in the future.
- Open Access
Public Health Genetics: Surveying Preparedness for the Next Generation of Public Health Professionals
Since the Human Genome Project’s completion in 2003, the need for increased population genetic literacy has grown exponentially. To address this need, public health professionals must be educated appropriately to serve the public best. This study examines the current state of public health genetics education within existing master of public health (MPH) programs. A total of 171 MPH Council on Education for Public Health Accreditation (CEPH)-accredited programs across the nation were identified via a preliminary internet search. The American Public Health Association (APHA) Genomics Forum Policy Committee created 14 survey questions to assess the current status of incorporating genetics/genomics education within MPH programs. Using the Qualtrics survey system through the University of Pittsburgh, a link to the anonymous survey was sent to each director’s email address obtained from their program’s website. There were 41 survey responses, with 37 finished to completion, for a response rate of 21.6% (37/171). A total of 75.7% (28/37) of respondents reported having courses containing genetics/genomics information in their programs’ coursework. Only 12.6% reported such coursework to be required for program completion. Commonly listed barriers to incorporating genetics/genomics include limited faculty knowledge and lack of space in existing courses and programs. Survey results revealed the incongruous and limited incorporation of genetics/genomics within the context of graduate-level public health education. While most recorded programs report offering public health genetics coursework, the extent and requirement of such instruction are not considered necessary for program completion, thereby potentially limiting the genetic literacy of the current pool of public health professionals.
Open AccessPublic Health Genetics: Surveying Preparedness for the Next Generation of Public Health Professionals
Since the Human Genome Project’s completion in 2003, the need for increased population genetic literacy has grown exponentially. To address this need, public health professionals must be educated appropriately to serve the public best. This study examines the current state of public health genetics education within existing master of public health (MPH) programs. A total of 171 MPH Council on Education for Public Health Accreditation (CEPH)-accredited programs across the nation were identified via a preliminary internet search. The American Public Health Association (APHA) Genomics Forum Policy Committee created 14 survey questions to assess the current status of incorporating genetics/genomics education within MPH programs. Using the Qualtrics survey system through the University of Pittsburgh, a link to the anonymous survey was sent to each director’s email address obtained from their program’s website. There were 41 survey responses, with 37 finished to completion, for a response rate of 21.6% (37/171). A total of 75.7% (28/37) of respondents reported having courses containing genetics/genomics information in their programs’ coursework. Only 12.6% reported such coursework to be required for program completion. Commonly listed barriers to incorporating genetics/genomics include limited faculty knowledge and lack of space in existing courses and programs. Survey results revealed the incongruous and limited incorporation of genetics/genomics within the context of graduate-level public health education. While most recorded programs report offering public health genetics coursework, the extent and requirement of such instruction are not considered necessary for program completion, thereby potentially limiting the genetic literacy of the current pool of public health professionals.
- Open Access
- 6 October 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (6) , 721-727
Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs
Cystinuria is a rare disorder resulting in development of recurrent kidney stones, adversely affecting patient quality of life. The goal of cystinuria management is to reduce stone formation by increasing cystine solubility in urine, which includes lowering the urinary cystine level below its solubility limit. Treatment usually involves alkalinization of the urine and often requires initiating pharmacotherapy with a cystine-binding thiol drug (CBTD) such as tiopronin; however, proper dose adjustment requires accurate measurement of urinary cystine. The goal of this study was to validate a novel high-performance liquid chromatography tandem mass spectrometry (HPLC–MS/MS) method for quantification of cystine in the urine of patients with cystinuria receiving a CBTD. Urine samples were collected over 24 h from 24 patients and separated into 2 aliquots. Chromatographic separation of samples was conducted and separation of cystine from the cysteine-tiopronin drug complex was complete in < 3 min. The method was validated for accuracy, precision, linearity, limit of detection (LOD), and limit of quantification (LOQ). Mean accuracy range was 97.7–102.3%; intermediate precision was high with relative percent difference values calculated at 1.2–9.3%; the calibration curve resulted in a linear response throughout the concentration range (R2 = 0.998); and the LOD and LOQ were 0.002 and 0.005 mg/mL, respectively. Mean (range) cystine concentrations measured were 111.10 (51.31–179.46) and 242.21 (61.14–741.80) g/L in Aliquots A and B, respectively. The HPLC–MS/MS method presented here indicates that urine cystine can be reliably quantified in patients receiving a CBTD.
- 6 October 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (6) , 721-727
Open AccessAccurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs
Cystinuria is a rare disorder resulting in development of recurrent kidney stones, adversely affecting patient quality of life. The goal of cystinuria management is to reduce stone formation by increasing cystine solubility in urine, which includes lowering the urinary cystine level below its solubility limit. Treatment usually involves alkalinization of the urine and often requires initiating pharmacotherapy with a cystine-binding thiol drug (CBTD) such as tiopronin; however, proper dose adjustment requires accurate measurement of urinary cystine. The goal of this study was to validate a novel high-performance liquid chromatography tandem mass spectrometry (HPLC–MS/MS) method for quantification of cystine in the urine of patients with cystinuria receiving a CBTD. Urine samples were collected over 24 h from 24 patients and separated into 2 aliquots. Chromatographic separation of samples was conducted and separation of cystine from the cysteine-tiopronin drug complex was complete in < 3 min. The method was validated for accuracy, precision, linearity, limit of detection (LOD), and limit of quantification (LOQ). Mean accuracy range was 97.7–102.3%; intermediate precision was high with relative percent difference values calculated at 1.2–9.3%; the calibration curve resulted in a linear response throughout the concentration range (R2 = 0.998); and the LOD and LOQ were 0.002 and 0.005 mg/mL, respectively. Mean (range) cystine concentrations measured were 111.10 (51.31–179.46) and 242.21 (61.14–741.80) g/L in Aliquots A and B, respectively. The HPLC–MS/MS method presented here indicates that urine cystine can be reliably quantified in patients receiving a CBTD.
- Open Access
- 25 October 2021
- Published by SAGE Publications in Public Health Reports®
- Vol. 137 (6) , 1242-1247
Are We Prepared for Precision Public Health? An Examination of Genomics Content in Graduate Public Health Programs
Objective: With the completion of the Human Genome Project and swift development of genomic technologies, public health practitioners can use these advancements to more precisely target disease interventions to populations at risk. To integrate these innovations into better health outcomes, public health professionals need to have at least a basic understanding of genomics within various disciplines of public health. This descriptive study focused on the current level of genomics content in accredited master of public health (MPH) programs in the United States. Methods: We conducted an internet search on all 171 Council on Education for Public Health (CEPH)–accredited MPH programs in the United States for genomics content in required and elective courses using the search terms “genetics,” “genomics,” and “molecular.” Results: Of the 171 CEPH-accredited MPH programs examined, 52 (30.4%) schools and programs in 34 states offered some type of genomics education. Thirty-five (20.5%) schools and programs had a course in genetic epidemiology, 29 (16.9%) had a course in genetic biostatistics or bioinformatics, and 17 (9.9%) had a course in general public health genomics. The remaining 119 offered no course with a focus on genetics or genomics. In addition, some electives or specifically focused courses related to genomics were offered. Conclusion: We found inadequate training in public health genomics for MPH students. To realize the promise of precision public health and to increase the understanding of genomics among the public health workforce, MPH programs need to find ways to integrate genomics education into their curricula.
- 25 October 2021
- Published by SAGE Publications in Public Health Reports®
- Vol. 137 (6) , 1242-1247
Open AccessAre We Prepared for Precision Public Health? An Examination of Genomics Content in Graduate Public Health Programs
Objective: With the completion of the Human Genome Project and swift development of genomic technologies, public health practitioners can use these advancements to more precisely target disease interventions to populations at risk. To integrate these innovations into better health outcomes, public health professionals need to have at least a basic understanding of genomics within various disciplines of public health. This descriptive study focused on the current level of genomics content in accredited master of public health (MPH) programs in the United States. Methods: We conducted an internet search on all 171 Council on Education for Public Health (CEPH)–accredited MPH programs in the United States for genomics content in required and elective courses using the search terms “genetics,” “genomics,” and “molecular.” Results: Of the 171 CEPH-accredited MPH programs examined, 52 (30.4%) schools and programs in 34 states offered some type of genomics education. Thirty-five (20.5%) schools and programs had a course in genetic epidemiology, 29 (16.9%) had a course in genetic biostatistics or bioinformatics, and 17 (9.9%) had a course in general public health genomics. The remaining 119 offered no course with a focus on genetics or genomics. In addition, some electives or specifically focused courses related to genomics were offered. Conclusion: We found inadequate training in public health genomics for MPH students. To realize the promise of precision public health and to increase the understanding of genomics among the public health workforce, MPH programs need to find ways to integrate genomics education into their curricula.
- Open Access
- 21 March 2019
- Published by SAGE Publications in Public Health Reports®
- Vol. 134 (3) , 228-233
Moving the Needle on Action Around Evidence-Based Screening for Hereditary Conditions: Preparing State Chronic Disease Directors to Advance Precision Public Health
- 21 March 2019
- Published by SAGE Publications in Public Health Reports®
- Vol. 134 (3) , 228-233
Open AccessMoving the Needle on Action Around Evidence-Based Screening for Hereditary Conditions: Preparing State Chronic Disease Directors to Advance Precision Public Health